November 07, 2021
Experts discuss the impact of misinformation in medicine at the current ACAAI annual scientific meeting.
October 24, 2021
Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.
October 21, 2021
Cantharidin 0.7% could be an emerging standard for molluscum treatment.
October 05, 2021
Optimizing rosacea treatment outcomes isn’t only about papules and pustules. Facial erythema needs to be part of an effective management plan.
September 01, 2021
COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.
July 30, 2021
As COVID-19 eases, the FDA is breaking through its backlog and clinical trials are moving forward, opening the way for a new wave of treatments.
June 22, 2021
The pro-inflammatory transcription factor is critical for the expression of IL-23, which is known to play a role in psoriasis.
June 18, 2021
Experts present detailed guidelines on how to diagnose and treat common skin diseases and conditions in the Asian American population.
May 26, 2021
Experts evaluate efficacy and safety of regenerative skin care products.
May 03, 2021
Study findings show calcipotriene-betamethasone foam to be safe and moderately effective in skin of color patients with psoriasis but failed to meet several secondary endpoints and to demonstrate statistically significant changes.
